UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Polypharmacy in schizophrenia

Basic & clinical pharmacology & toxicology, 2020-03, Vol.126 (3), p.183-192

Baandrup, Lone

2020

Volltextzugriff (PDF)

Social zeitgebers and circadian dysrhythmia are associated with severity of symptoms of PTSD and depression in trauma-affected refugees

European archives of psychiatry and clinical neuroscience, 2021-10, Vol.271 (7), p.1319-1329

2021

Volltextzugriff (PDF)

Managing the hazards of cannabis use

Acta psychiatrica Scandinavica, 2022-03, Vol.145 (3), p.231-233

Baandrup, Lone

2022

Volltextzugriff (PDF)

Effect of a dynamic lighting intervention on circadian rest-activity disturbances in cognitively impaired, older adults living in a nursing home: A proof-of-concept study

Neurobiology of sleep and circadian rhythms, 2021-11, Vol.11, p.100067-100067, Article 100067

2021

Volltextzugriff (PDF)

Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial

BMC psychiatry, 2021-08, Vol.21 (1), p.1-404, Article 404

2021

Volltextzugriff (PDF)

Sleep impairments in refugees diagnosed with post-traumatic stress disorder: a polysomnographic and self-report study

European journal of psychotraumatology, 2023, Vol.14 (1), p.2185943-2185943

2023

Volltextzugriff (PDF)

Value of gym-based group exercise versus usual care for young adults receiving antipsychotic medication: study protocol for the multicenter randomized controlled Vega trial

BMC psychiatry, 2023-08, Vol.23 (1), p.1-634, Article 634

2023

Volltextzugriff (PDF)

Treatment of sleep disturbances in trauma-affected refugees: Study protocol for a randomised controlled trial

Trials, 2017-11, Vol.18 (1), p.520-13, Article 520

2017

Volltextzugriff (PDF)

White matter microstructure and sleep-wake disturbances in individuals at ultra-high risk of psychosis

Frontiers in human neuroscience, 2022-10, Vol.16, p.1029149-1029149

2022

Volltextzugriff (PDF)

Management of dyslipidaemia in individuals with severe mental illness: a population-based study in the Greater Copenhagen Area

Therapeutic advances in psychopharmacology, 2023-01, Vol.13, p.20451253231211574-20451253231211574

2023

Volltextzugriff (PDF)

Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial

BMC psychiatry, 2016-10, Vol.16 (1), p.348-348, Article 348

2016

Volltextzugriff (PDF)

Onset of Action of Selected Second-Generation Antipsychotics (Pines)-A Systematic Review and Meta-Analyses

Biomedicines, 2022-12, Vol.11 (1), p.82

2022

Volltextzugriff (PDF)

Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers

Frontiers in psychiatry, 2018-02, Vol.9, p.22-22

2018

Volltextzugriff (PDF)

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol

Frontiers in pharmacology, 2020-04, Vol.11, p.591-591

2020

Volltextzugriff (PDF)

Incident users of antipsychotics: who are they and how do they fare?

Social Psychiatry and Psychiatric Epidemiology, 2016-04, Vol.51 (4), p.505-512

2016

Volltextzugriff (PDF)

Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo

European archives of psychiatry and clinical neuroscience, 2017-03, Vol.267 (2), p.163-171

2017

Volltextzugriff (PDF)

Improving quality of care among patients hospitalised with schizophrenia: a nationwide initiative

BJPsych open, 2015-06, Vol.1 (1), p.48-53

2015

Volltextzugriff (PDF)

How Dosing Might Influence the Conclusion in an Antipsychotic Polypharmacy Effectiveness Trial

The American journal of psychiatry, 2011-10, Vol.168 (10), p.1117-1117

Baandrup, Lone

2011

Volltextzugriff (PDF)

Changing prescribing practice for rapid tranquillization–a quality improvement project based on the Plan-Do-Study-Act method

Social Psychiatry and Psychiatric Epidemiology, 2024-05, Vol.59 (5), p.781-788

2024

Volltextzugriff (PDF)

Immunohistochemical Demonstration of Vascular Endothelial Growth Factor in Vestibular Schwannomas Correlates to Tumor Growth Rate

The Laryngoscope, 2003-12, Vol.113 (12), p.2129-2134

2003

Volltextzugriff (PDF)

Imagery rehearsal therapy and/or mianserin in treatment of refugees diagnosed with PTSD: Results from a randomized controlled trial

Journal of sleep research, 2021-08, Vol.30 (4), p.e13276-n/a

2021

Volltextzugriff (PDF)

Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol

BMC psychiatry, 2011-10, Vol.11 (1), p.160-160, Article 160

2011

Volltextzugriff (PDF)

Increased all-cause mortality with use of psychotropic medication in dementia patients and controls: A population-based register study

European neuropsychopharmacology, 2015-11, Vol.25 (11), p.1906-1913

2015

Volltextzugriff (PDF)

Investigating the link between subjective sleep quality, symptoms of PTSD, and level of functioning in a sample of trauma-affected refugees

Sleep (New York, N.Y.), 2021-09, Vol.44 (9), p.1

2021

Volltextzugriff (PDF)

Evaluating the implementation and use of patient-reported outcome measures in a mental health hospital in Denmark: a qualitative study

International journal for quality in health care, 2022-03, Vol.34 (Supplement_1), p.ii49-ii58

2022

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(79)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(67)
Science & Technology
(67)
Humans
(45)
Psychiatry
(41)
Schizophrenia
(27)
Male
(25)
Adult
(24)
Female
(21)
Middle Aged
(18)
Neurosciences & Neurology
(16)
Schizophrenia - Drug Therapy
(16)
Antipsychotic Agents - Therapeutic Use
(15)
Antipsychotics
(15)
Psychotropic Drugs
(15)
Clinical Neurology
(14)
Psychosis
(13)
Melatonin
(11)
Mental Disorders
(11)
Neurosciences
(11)
Adolescent
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Polypharmacy in schizophrenia

Social zeitgebers and circadian dysrhythmia are associated with severity of symptoms of PTSD and depression in trauma-affected refugees

Managing the hazards of cannabis use

Effect of a dynamic lighting intervention on circadian rest-activity disturbances in cognitively impaired, older adults living in a nursing home: A proof-of-concept study

Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial

Sleep impairments in refugees diagnosed with post-traumatic stress disorder: a polysomnographic and self-report study

Value of gym-based group exercise versus usual care for young adults receiving antipsychotic medication: study protocol for the multicenter randomized controlled Vega trial

Treatment of sleep disturbances in trauma-affected refugees: Study protocol for a randomised controlled trial

White matter microstructure and sleep-wake disturbances in individuals at ultra-high risk of psychosis

Management of dyslipidaemia in individuals with severe mental illness: a population-based study in the Greater Copenhagen Area

Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial

Onset of Action of Selected Second-Generation Antipsychotics (Pines)-A Systematic Review and Meta-Analyses

Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol

Incident users of antipsychotics: who are they and how do they fare?

Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo

Improving quality of care among patients hospitalised with schizophrenia: a nationwide initiative

How Dosing Might Influence the Conclusion in an Antipsychotic Polypharmacy Effectiveness Trial

Changing prescribing practice for rapid tranquillization–a quality improvement project based on the Plan-Do-Study-Act method

Immunohistochemical Demonstration of Vascular Endothelial Growth Factor in Vestibular Schwannomas Correlates to Tumor Growth Rate

Imagery rehearsal therapy and/or mianserin in treatment of refugees diagnosed with PTSD: Results from a randomized controlled trial

Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol

Increased all-cause mortality with use of psychotropic medication in dementia patients and controls: A population-based register study

Investigating the link between subjective sleep quality, symptoms of PTSD, and level of functioning in a sample of trauma-affected refugees

Evaluating the implementation and use of patient-reported outcome measures in a mental health hospital in Denmark: a qualitative study

Suchergebnisse filtern